Related references
Note: Only part of the references are listed.Machine learning for multi-omics data integration in cancer
Zhaoxiang Cai et al.
ISCIENCE (2022)
Benchmarking of analysis strategies for data-independent acquisition proteomics using a large-scale dataset comprising inter-patient heterogeneity
Klemens Froehlich et al.
NATURE COMMUNICATIONS (2022)
Pan-cancer proteomic map of 949 human cell lines
Emanuel Goncalves et al.
CANCER CELL (2022)
Computational estimation of quality and clinical relevance of cancer cell lines
Lucia Trastulla et al.
MOLECULAR SYSTEMS BIOLOGY (2022)
HarmonizR enables data harmonization across independent proteomic datasets with appropriate handling of missing values
Hannah Voss et al.
NATURE COMMUNICATIONS (2022)
A review of COVID-19 biomarkers and drug targets: resources and tools
Francesca P. Caruso et al.
BRIEFINGS IN BIOINFORMATICS (2021)
A genome-scale CRISPR screen reveals factors regulating Wnt-dependent renewal of mouse gastric epithelial cells
Kazuhiro Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment
Henry Rodriguez et al.
CELL (2021)
Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
Fangyoumin Feng et al.
JOURNAL OF GENETICS AND GENOMICS (2021)
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta et al.
MOLECULAR DIVERSITY (2021)
Improved identification and quantification of peptides in mass spectrometry data via chemical and random additive noise elimination (CRANE)
Akila J. Seneviratne et al.
BIOINFORMATICS (2021)
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
Clemens Gutmann et al.
NATURE COMMUNICATIONS (2021)
A time-resolved proteomic and prognostic map of COVID-19
Vadim Demichev et al.
CELL SYSTEMS (2021)
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
Yayoi Kimura et al.
SCIENTIFIC REPORTS (2021)
DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput
Vadim Demichev et al.
NATURE METHODS (2020)
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
David P. Nusinow et al.
CELL (2020)
Data-Independent Acquisition Mass Spectrometry-Based Proteomics and Software Tools: A Glimpse in 2020
Fangfei Zhang et al.
PROTEOMICS (2020)
High-throughput screening of human induced pluripotent stem cell-derived brain organoids
Madel Durens et al.
JOURNAL OF NEUROSCIENCE METHODS (2020)
A streamlined mass spectrometry-based proteomics workflow for large-scale FFPE tissue analysis
Fabian Coscia et al.
JOURNAL OF PATHOLOGY (2020)
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
Alejandro Barredo Arrieta et al.
INFORMATION FUSION (2020)
Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns
Marina Salvadores et al.
SCIENCE ADVANCES (2020)
Machine learning approaches to drug response prediction: challenges and recent progress
George Adam et al.
NPJ PRECISION ONCOLOGY (2020)
Drug mechanism-of-action discovery through the integration of pharmacological andCRISPRscreens
Emanuel Goncalves et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Human organoids: model systems for human biology and medicine
Jihoon Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Proteome activity landscapes of tumor cell lines determine drug responses
Martin Frejno et al.
NATURE COMMUNICATIONS (2020)
Strategies to enable large-scale proteomics for reproducible research
Rebecca C. Poulos et al.
NATURE COMMUNICATIONS (2020)
diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition
Florian Meier et al.
NATURE METHODS (2020)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate
Emerson Y. Chen et al.
JAMA INTERNAL MEDICINE (2019)
Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines
Xing Yi Woo et al.
BMC MEDICAL GENOMICS (2019)
Addressing the Challenges of High-Throughput Cancer Tissue Proteomics for Clinical Application: ProCan
Brett Tully et al.
PROTEOMICS (2019)
PDX Finder: A portal for patient-derived tumor xenograft model discovery
Nathalie Conte et al.
NUCLEIC ACIDS RESEARCH (2019)
Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines
Tiannan Guo et al.
ISCIENCE (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies
Maciej Daniszewski et al.
SLAS TECHNOLOGY (2018)
The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
Jaeyun Jung et al.
CANCER RESEARCH AND TREATMENT (2018)
Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial
Christina Ludwig et al.
MOLECULAR SYSTEMS BIOLOGY (2018)
TCGA-assembler 2: software pipeline for retrieval and processing of TCGA/CPTAC data
Lin Wei et al.
BIOINFORMATICS (2018)
Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations
Savita Nandal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry
Ben C. Collins et al.
NATURE COMMUNICATIONS (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
The Promises of Quantitative Proteomics in Precision Medicine
Bhagwat Prasad et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Lu Zhang et al.
DRUG DISCOVERY TODAY (2017)
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
Andrew Goodspeed et al.
MOLECULAR CANCER RESEARCH (2016)
Can we open the black box of AI?
Davide Castelvecchi
NATURE (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
The CPTAC Data Portal: A Resource for Cancer Proteomics Research
Nathan J. Edwards et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Pharmacogenomic agreement between two cancer cell line data sets
Nicolas Stransky et al.
NATURE (2015)
Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps
Tiannan Guo et al.
NATURE MEDICINE (2015)
Machine learning: Trends, perspectives, and prospects
M. I. Jordan et al.
SCIENCE (2015)
On Pixel-Wise Explanations for Non-Linear Classifier Decisions by Layer-Wise Relevance Propagation
Sebastian Bach et al.
PLOS ONE (2015)
OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data
Hannes L. Roest et al.
NATURE BIOTECHNOLOGY (2014)
A repository of assays to quantify 10,000 human proteins by SWATH-MS
George Rosenberger et al.
SCIENTIFIC DATA (2014)
Significance of immunohistochemistry in breast cancer
Dana Carmen Zaha
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Global Proteome Analysis of the NCI-60 Cell Line Panel
Amin Moghaddas Gholami et al.
CELL REPORTS (2013)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: A multicohort cross-institutional study
Fumiko Taguchi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer
Dhafir Al-Azawi et al.
BMC CANCER (2006)
The role of drug-metabolising enzymes in clinical responses to chemotherapy
Charity D. Scripture et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
UPLC/MSE; a new approach for generating molecular fragment information for biomarker structure elucidation (vol 20, pg 1989, 2006)
Robert S. Plumb et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
SW Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pharmacoproteomics in drug development
FA Witzmann et al.
PHARMACOGENOMICS JOURNAL (2003)
Share Paper
